Meta-analysis on the Efficacy and Side effect of Inhaled Corticosteroids for Adult and Adolescent Asthma

( views:698, downloads:0 )
Author:
MENG Rui(Department of Respiratory Medicine, Daqing Oilfields General Hospital, Daqing 163001, China)
LI Bo()
SHI Yi-hai()
()
()
()
()
Journal Title:
CHINA CLINICAL PRACTICAL MEDICINE
Issue:
Volume 04, Issue 12, 2010
DOI:
10.3760/cma.j.issn 1673-8799.2010.12.19
Key Word:
Meta analysis;Inhaled corticosteroids;Asthma;Efficacy;Side effect

Abstract: Objective To assess the efficacy and side effect of inhaled corticosteroids for adult and adolescent asthma. Methods According to the requirements of Cochrane systematic review, a thorough literature search was performed among PUBMED, China National Knowledge Infrastructure, and so on. By RevMan 4.2software, a meta analysis was performed on a total of 2356 patients involved in 13 papers which met with the inclusion criteria. Results The literatures of morning and evening peak expiratory flow(PEF) and forced vital capacity(FVC) and the occurrence of indisposition of pharyngeal portion had homogeneity. The literatures of forced expiratory volume in one second(FEV1)and FEV1 percent predicted(FEV1 %)and the occurrence of adverse events and ineffective of treatment had heterogeneity. Comparing the treatment groups with the control groups, the incorporation of FEV1 、FEV1% 、morning PEF and the occurrence of adverse events and ineffective of treatment were statistically significant. While the other three incorporations of FVC and evening PEF and the occurrence of indisposition of pharyngeal portion were not. Sensitivity analysis showed that the results were stable and reliable. The results of publication bias showed that the impact was small, and the results was reliable.Conclusion The clinical evidences available so far indicated that the treatment of adult and adolescent asthma with inhaled corticosteroids is effective and has less side effect, although rigorous design and large sample size randomized double-blind clinical trials are required to further analysis for more stable and reliable results.

  • [1]Masoli M,Fabian D,Holt S,et al.The global burden of asthma:executive summary of the GINA Dissemination Committee report.Allegy,2004,59:469-478.
  • [2]中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案).中华结核和呼吸杂志,2003,26(3):132-138.
  • [3]李幼平.循证医学.高等教育出版社,2003:3.
  • [4]Pearlman D.S,Berger WE,Kerwin E,et al.Once-daily ciclesonide improves lung function and is well tolerated by patients withmild-to-moderate persistent asthma.J Allergy Clin Immunol,2005,116(6):1206.
  • [5]Langdon C.G,Adler M,Mehra S,et al.Once-daily ciclesonide 80or 320 microg for 12 weeks is safe and effective in patients with persistent asthma.Respir Med,2005,99 (10):1275-1285.
  • [6]Chapman K.R,Patel P,D Urzo AD,et al.Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.Allergy,2005,60(3):330-337.
  • [7]Baumgartner R.A,Martinez G,Edelman JM,et al.Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone.Eur Respir J,2003,21 (1):123-128.
  • [8]Yurdakul A.S,Taci N,Eren A,et al.Comparative efficacy of oncedaily therapy with inhaled corticosteroid,leukotriene antagonist or sustained-release theophylline in patients with mild persistent asthma.Respir Med,2003,97(12):1313-1319.
  • [9]Riccioni G,Vecchia RD,D' Orazio N,et al.Comparison of montelukast and budesonide on bronchial reactivity in subjects with mildmoderate persistent asthma.Pulm Pharmacol Ther,2003,16 (2):111-114.
  • [10]Bousquet J,Aubier M,Sastre J,et al.Comparison of roflumilast,an oral anti-inflammatory,with beclomethasone dipropionate in the treatment of persistent asthma.Allergy,2006,61 (1):72-78.
  • [11]Adachi M,Ishihara K,Inoue H,et al.Efficacy and safety of oncedaily inhaled ciclesonide in adults with mild to moderate asthma:a double-blind,placebo-controlled study.Respirology,2007,12(4):566-572.
  • [12]张祖贻,尹静萍,王光杰,等.布地奈德气雾剂治疗支气管哮喘的疗效观察.南京铁道医学院学报,1995,14(3):175-177.
  • [13]曹鄂洪,童茂荣,康晓明,等.布地奈德气雾剂治疗支气管哮喘的疗效评价.南京大学学报(自然科学),1998,34(2):223-226.
  • [14]尹玉琴.皮质类固醇吸入治疗支气管哮喘疗效观察.山东医药,2003,43(31):4-6.
  • [15]颜雪琴,戴元荣,翁海霞,等.布地奈德吸入剂治疗支气管哮喘的疗效.中国新药杂志,2002,11(7):557-559.
  • [16]谢宝辉,邓新宇,焦维克.普米克都保治疗38例轻度支气管哮喘疗效观察.福建医药杂志,2007,29(1):141
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn